Global Immune Checkpoint Inhibitors Market Research Report 2019

Table of Contents

Executive Summary

1 Immune Checkpoint Inhibitors Market Overview

• 1.1 Product Overview and Scope of Immune Checkpoint Inhibitors
• 1.2 Immune Checkpoint Inhibitors Segment by Type
  • 1.2.1 Global Immune Checkpoint Inhibitors Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 PD-1/PD-L1
  • 1.2.3 CTLA-4
• 1.3 Immune Checkpoint Inhibitors Segment by Application
  • 1.3.1 Immune Checkpoint Inhibitors Consumption Comparison by Application (2014-2025)
  • 1.3.2 Lung Cancer
  • 1.3.3 Colorectal Cancer
  • 1.3.4 Breast Cancer
  • 1.3.5 Prostate Cancer
  • 1.3.6 Melanoma
  • 1.3.7 Blood Cancer
  • 1.3.8 Other
• 1.4 Global Immune Checkpoint Inhibitors Market by Region
  • 1.4.1 Global Immune Checkpoint Inhibitors Market Size Region
  • 1.4.2 North America Status and Prospect (2014-2025)
  • 1.4.3 Europe Status and Prospect (2014-2025)
  • 1.4.4 China Status and Prospect (2014-2025)
  • 1.4.5 Japan Status and Prospect (2014-2025)
• 1.5 Global Immune Checkpoint Inhibitors Market Size
  • 1.5.1 Global Immune Checkpoint Inhibitors Revenue (2014-2025)
  • 1.5.2 Global Immune Checkpoint Inhibitors Production (2014-2025)

2 Global Immune Checkpoint Inhibitors Market Competition by Manufacturers

• 2.1 Global Immune Checkpoint Inhibitors Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Immune Checkpoint Inhibitors Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Immune Checkpoint Inhibitors Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Immune Checkpoint Inhibitors Production Sites, Area Served, Product Types
• 2.5 Immune Checkpoint Inhibitors Market Competitive Situation and Trends
  • 2.5.1 Immune Checkpoint Inhibitors Market Concentration Rate
  • 2.5.2 Immune Checkpoint Inhibitors Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Immune Checkpoint Inhibitors Production Market Share by Regions

• 3.1 Global Immune Checkpoint Inhibitors Production Market Share by Regions
• 3.2 Global Immune Checkpoint Inhibitors Revenue Market Share by Regions (2014-2019)
• 3.3 Global Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Immune Checkpoint Inhibitors Production
  • 3.4.1 North America Immune Checkpoint Inhibitors Production Growth Rate (2014-2019)
  • 3.4.2 North America Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Immune Checkpoint Inhibitors Production
  • 3.5.1 Europe Immune Checkpoint Inhibitors Production Growth Rate (2014-2019)
  • 3.5.2 Europe Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Immune Checkpoint Inhibitors Production (2014-2019)
  • 3.6.1 China Immune Checkpoint Inhibitors Production Growth Rate (2014-2019)
  • 3.6.2 China Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Immune Checkpoint Inhibitors Production (2014-2019)
  • 3.7.1 Japan Immune Checkpoint Inhibitors Production Growth Rate (2014-2019)
  • 3.7.2 Japan Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Immune Checkpoint Inhibitors Consumption by Regions

• 4.1 Global Immune Checkpoint Inhibitors Consumption by Regions
• 4.2 North America Immune Checkpoint Inhibitors Consumption (2014-2019)
• 4.3 Europe Immune Checkpoint Inhibitors Consumption (2014-2019)
• 4.4 China Immune Checkpoint Inhibitors Consumption (2014-2019)
• 4.5 Japan Immune Checkpoint Inhibitors Consumption (2014-2019)

5 Global Immune Checkpoint Inhibitors Production, Revenue, Price Trend by Type

• 5.1 Global Immune Checkpoint Inhibitors Production Market Share by Type (2014-2019)
• 5.2 Global Immune Checkpoint Inhibitors Revenue Market Share by Type (2014-2019)
• 5.3 Global Immune Checkpoint Inhibitors Price by Type (2014-2019)
• 5.4 Global Immune Checkpoint Inhibitors Production Growth by Type (2014-2019)

6 Global Immune Checkpoint Inhibitors Market Analysis by Applications

• 6.1 Global Immune Checkpoint Inhibitors Consumption Market Share by Application (2014-2019)
• 6.2 Global Immune Checkpoint Inhibitors Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Immune Checkpoint Inhibitors Business

• 7.1 Bristol Myer Squibb
  • 7.1.1 Bristol Myer Squibb Immune Checkpoint Inhibitors Production Sites and Area Served
  • 7.1.2 Immune Checkpoint Inhibitors Product Introduction, Application and Specification
  • 7.1.3 Bristol Myer Squibb Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 AstraZeneca
  • 7.2.1 AstraZeneca Immune Checkpoint Inhibitors Production Sites and Area Served
  • 7.2.2 Immune Checkpoint Inhibitors Product Introduction, Application and Specification
  • 7.2.3 AstraZeneca Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Merck & Co.
  • 7.3.1 Merck & Co. Immune Checkpoint Inhibitors Production Sites and Area Served
  • 7.3.2 Immune Checkpoint Inhibitors Product Introduction, Application and Specification
  • 7.3.3 Merck & Co. Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Roche / Genentech
  • 7.4.1 Roche / Genentech Immune Checkpoint Inhibitors Production Sites and Area Served
  • 7.4.2 Immune Checkpoint Inhibitors Product Introduction, Application and Specification
  • 7.4.3 Roche / Genentech Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 Incyte Corporation
  • 7.5.1 Incyte Corporation Immune Checkpoint Inhibitors Production Sites and Area Served
  • 7.5.2 Immune Checkpoint Inhibitors Product Introduction, Application and Specification
  • 7.5.3 Incyte Corporation Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 NewLink Genetics
  • 7.6.1 NewLink Genetics Immune Checkpoint Inhibitors Production Sites and Area Served
  • 7.6.2 Immune Checkpoint Inhibitors Product Introduction, Application and Specification
  • 7.6.3 NewLink Genetics Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 ArGEN-X
  • 7.7.1 ArGEN-X Immune Checkpoint Inhibitors Production Sites and Area Served
  • 7.7.2 Immune Checkpoint Inhibitors Product Introduction, Application and Specification
  • 7.7.3 ArGEN-X Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Seattle Genetics
  • 7.8.1 Seattle Genetics Immune Checkpoint Inhibitors Production Sites and Area Served
  • 7.8.2 Immune Checkpoint Inhibitors Product Introduction, Application and Specification
  • 7.8.3 Seattle Genetics Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Pfizer
  • 7.9.1 Pfizer Immune Checkpoint Inhibitors Production Sites and Area Served
  • 7.9.2 Immune Checkpoint Inhibitors Product Introduction, Application and Specification
  • 7.9.3 Pfizer Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 MacroGenics
  • 7.10.1 MacroGenics Immune Checkpoint Inhibitors Production Sites and Area Served
  • 7.10.2 Immune Checkpoint Inhibitors Product Introduction, Application and Specification
  • 7.10.3 MacroGenics Immune Checkpoint Inhibitors Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Celldex Therapeutics
• 7.12 CureTech
• 7.13 Immutep
• 7.14 Innate Pharma
• 7.15 Sorrento Therapeutics
• 7.16 GlaxoSmithKline
• 7.17 GITR, Inc

8 Immune Checkpoint Inhibitors Manufacturing Cost Analysis

• 8.1 Immune Checkpoint Inhibitors Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Immune Checkpoint Inhibitors
• 8.4 Immune Checkpoint Inhibitors Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Immune Checkpoint Inhibitors Distributors List
• 9.3 Immune Checkpoint Inhibitors Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Immune Checkpoint Inhibitors Market Forecast

• 11.1 Global Immune Checkpoint Inhibitors Production, Revenue Forecast
  • 11.1.1 Global Immune Checkpoint Inhibitors Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Immune Checkpoint Inhibitors Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Immune Checkpoint Inhibitors Price and Trend Forecast (2019-2025)
• 11.2 Global Immune Checkpoint Inhibitors Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Immune Checkpoint Inhibitors Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Immune Checkpoint Inhibitors Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Immune Checkpoint Inhibitors Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Immune Checkpoint Inhibitors Production, Revenue Forecast (2019-2025)
• 11.3 Global Immune Checkpoint Inhibitors Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Immune Checkpoint Inhibitors Consumption Forecast (2019-2025)
  • 11.3.2 Europe Immune Checkpoint Inhibitors Consumption Forecast (2019-2025)
  • 11.3.3 China Immune Checkpoint Inhibitors Consumption Forecast (2019-2025)
  • 11.3.4 Japan Immune Checkpoint Inhibitors Consumption Forecast (2019-2025)
• 11.4 Global Immune Checkpoint Inhibitors Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Immune Checkpoint Inhibitors Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List